XML 114 R96.htm IDEA: XBRL DOCUMENT v3.22.4
Investments in and Advances to Joint Ventures - Summary of Financial Information for Unconsolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule Of Equity Method Investments [Line Items]      
Current assets $ 1,719,783 $ 1,632,351  
Total assets 4,198,142 3,830,940  
Current liabilities 1,108,119 1,030,784  
Total liabilities 2,102,207 1,893,828  
Total joint venture equity 2,043,570 1,900,768  
Investments in and advances to unconsolidated joint ventures 107,425 110,688  
Revenue 4,195,272 3,660,771 $ 3,918,946
Costs 3,248,550 2,807,950 3,042,087
Net income attributable to Parsons Corporation 96,664 64,072 98,541
Equity in earnings of unconsolidated joint ventures 16,347 36,862 30,059
Unconsolidated Joint Ventures      
Schedule Of Equity Method Investments [Line Items]      
Equity in earnings of unconsolidated joint ventures 16,347 36,862 30,059
Unconsolidated Joint Ventures      
Schedule Of Equity Method Investments [Line Items]      
Current assets 1,610,246 1,620,735  
Noncurrent assets 491,658 531,261  
Total assets 2,101,904 2,151,996  
Current liabilities 1,255,297 1,088,985  
Noncurrent liabilities 468,056 669,911  
Total liabilities 1,723,353 1,758,896  
Total joint venture equity 378,551 393,100  
Investments in and advances to unconsolidated joint ventures 107,425 110,688  
Revenue 2,406,407 2,709,305 1,830,802
Costs 2,325,472 2,536,403 1,709,933
Net income attributable to Parsons Corporation $ 80,935 $ 172,902 $ 120,869